We are live on ! Find out more
SCPH

scPharmaceuticals
SCPH

Delisted

SCPH was delisted on the 6th of October, 2025.

Back to rankings

35 hedge funds and large institutions have $47.3M invested in scPharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 7

3% more capital invested

Capital invested by funds: $45.8M → $47.3M (+$1.5M)

0.26% less ownership

Funds ownership: 43.65% → 43.39% (-0.26%)

15% less funds holding

Funds holding: 41 → 35 (-6)

75% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 8

Holders
35
Holders Change
-6
Holders Change %
-14.63%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
14
Reduced
7
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AIC
AWM Investment Company
New York
+$326K
2
PPA
Parametric Portfolio Associates
Washington
+$170K
3
JP Morgan Chase
JP Morgan Chase
New York
+$107K
4
State Street
State Street
Massachusetts
+$84.9K
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$26.7K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$267K
2
Goldman Sachs
Goldman Sachs
New York
-$150K
3
CG
Colony Group
Massachusetts
-$131K
4
Millennium Management
Millennium Management
New York
-$109K
5
Citadel Advisors
Citadel Advisors
Florida
-$95K

SCPH Hedge Fund Activity: Q3 2018 in Review

35 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in scPharmaceuticals (SCPH) for Q3 2018, worth a combined $47.3M — up 3.3% from $45.8M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of SCPH and 2 opened new positions — a net loss of 6 holders — while 7 trimmed existing stakes and 14 added.

The largest buyer was AWM Investment Company, adding an estimated $326K. The largest seller was Morgan Stanley, cutting an estimated $267K.

  • 35 institutional investors held scPharmaceuticals (SCPH) as of Q3 2018, down from 41 in Q2 2018.
  • Funds reported $47.3M of scPharmaceuticals stock for Q3 2018, up 3.3% quarter-over-quarter.
  • 2 funds opened new scPharmaceuticals positions in Q3 2018 and 8 closed out, a net change of -6 holders.
  • The largest scPharmaceuticals buyer in Q3 2018 was AWM Investment Company, an estimated $326K added.
  • The largest scPharmaceuticals seller in Q3 2018 was Morgan Stanley, an estimated $267K sold.

Based on aggregated 13F filings for Q3 2018.